Atlas Trials

Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents

Clinical trial NCT00412503 · COMPLETED

Trial details

NCT number
NCT00412503
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Refractory TumorsMalignant Tumors

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.